Antiarrhythmic effects of polyunsaturated fatty acids: Recent studies

Circulation

Volumn 94, Issue 7, 1996, Pages 1774-1780

  Kang, Jing X ^a   Leaf, Alexander ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

death, sudden; fatty acids; fibrillation

Indexed keywords

ACYLCARNITINE; ANTIARRHYTHMIC AGENT; ARACHIDONIC ACID; CALCIMYCIN; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; INTRALIPID; ISOPRENALINE; LINOLEIC ACID; LINOLENIC ACID; LYSOPHOSPHATIDYLCHOLINE; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OUABAIN; POLYUNSATURATED FATTY ACID; SODIUM CHANNEL; SOYBEAN OIL; VEGETABLE OIL;

ANTIARRHYTHMIC ACTIVITY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIET THERAPY; FAT INTAKE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH;

EID: 0029778446     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.7.1774     Document Type: Review

References (52)

1. Kromann N, Green A. Epidemiologic studies in the Upernavik district, Greenland: incidence of some chronic diseases 1950-1974. Acta Med Scand. 1980;208:401-406.
2. Bang HO, Dyerberg J, Horne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand. 1976;200:69-73.
3. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med. 1995;332:977-982.
4. Kromhout D, Feskens JM, Bowles CH. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. Int J Epidemiol 1995;24:340-345.
5. Salonen JT, Seppänen K, Nyysönen, Korpela H, Kuahanen J, Kantola M, Tuomilehto J, Esterbauer H, Tatzber F, Salonen R. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation. 1995;91:645-655.
6. Gudbjarnason S, Hallgrimsson J. The role of myocardial membrane lipids in the development of cardiac necrosis. Acta Med Scand. 1975;587(suppl):17-26.
7. Murnaghan MF. Effects of fatty acids on the ventricular arrhythmia threshold in the isolated heart of the rabbit. Br J Pharmacol. 1981;73:909-915.
8. McLennan PL, Abeywardena MY, Charnock JS. Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats. Can J Physiol Pharmacol. 1985;63:1411-1417.
9. McLennan PL. Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am J Clin Nutr. 1993;57:207-212.
10. McLennan PL, Bridle TM, Abeywardena MY, Charnock JS. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am Heart J. 1992;123:1555-1561.
11. Billman GE, Hallaq H, Leaf A. Prevention of ischemia-induced ventricular fibrillation by ω-3 tatty acids. Proc Natl Acad Sci U S A. 1994;91:4427-4430.
12. Kang JX, Leaf A. Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A. 1994;91:9886-9890.
13. Kang JX, Leaf A. Prevention and termination of the β-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes. Biochem Biophys Res Commun. 1995;208:629-636.
14. Kang JX, Leaf A. Prevention and termination of arrhythmias induced by lysophosphatidyl choline and acylcarnitine in neonatal rat cardiac myocytes by free omega-3 polyunsaturated fatty acids. Eur J Pharmacol. 1996;297:97-106.
15. Cistola DP, Small DM, Hamilton JA. Carbon-13 NMR studies of saturated fatty acids bound to bovine serum albumin, I: the filling of individual fatty acid binding sites. J Biol Chem. 1987;262:10971-10985.
16. Capdevila J, Gil L, Orellana M, Marnett LJ, Mason JI, Yadagiri P, Falck JR. Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. Arch Biochem Biophys. 1988;261:257-263.
17. Tobias LD, Hamilton JG. The effect of 5,8,11,14-eicosatetraynoic on lipid metabolism. Lipids. 1978;14:181-193.
18. Kang JX, Leaf A. Protective effect of all-trans-retinoic acid against cardiac arrhythmias induced by isoproterenol, lysophosphatidylcholine or ischemia and reperfusion. J Cardiovasc Pharmacol. 1995;26:943-948.
19. Kang JX, Xiao YF, Leaf A. Free long-chain polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A. 1995;92:3997-4001.
20. + channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A. 1995;92:11000-11004.
21. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol. 1977;69:497-515.
22. Vaughan-Williams EMV. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol. 1984;24:129-147.
23. Coraboeuf E, Deroubaix E, Coulombe A. Effect of tetrodotoxin on action potentials of the conducting system in the dog heart. Am J Physiol. 1979;236:H561-H567.
24. + channels by directly binding to the channel proteins. Proc Natl Acad Med Sci U S A. 1996;93:3542-3546.
25. 3H]batra-chotoxinin A 20-α-benzoate to sodium channels by local anesthetics. Mol Pharmacol. 1984;25:219-227.
26. Sheldon RS, Cannon NJ, Duff HJ. A receptor for type 1 antiarrhythmic drugs associated with rat cardiac sodium channels. Circ Res. 1987;61:492-497.
27. Catterall WA. Structure and function of voltage-sensitive ion channels. Science 1988;242:50-61.
28. Taouis M, Sheldon RS, Duff HJ. Upregulation of the rat cardiac sodium channel by in vivo treatment with a class I anti arrhythmic drug. J Clin Invest. 1991;88:375-378.
29. Duff HJ, Offord J, West J, Catterall WA. Class I and IV antiarrhythmic drugs and cytosolic calcium regulate mRNA encoding the sodium channel α subunit in rat cardiac muscle. Mol Pharmacol. 1992;42:570-574.
30. Honore E, Barhanin J, Attali B, Lesage F, Lazdunski M. External blockade of the major cardiac delayed-rectifier K+ (Kvl.5) by poly-unsaturated fatty acids. Proc Natl Acad Sci U S A. 1994;91:1937-1941.
31. + current. Biophys J. 1995;68.-A108. Abstract.
32. Kim D, Clapham DE. Potassium channels in cardiac cells activated by arachidonic acid and phospholipids. Science. 1989;244:1174-1176.
33. + channels in cardiac myocytes by free fatty acids. Circ Res. 1990;67:1040-1046.
34. + channel properties induced by fatty acids in neuroblastoma cells. Eur J Physiol. 1991;419:467-471.
35. Ordway RW, Walsh JW Jr, Singer JJ. Arachidonic acid and other fatty acids directly activate potassium channels in smooth muscle cells. Science. 1989;244:1176-1179.
36. + channels in vascular smooth muscle cells. Fed Exp Biol Soc. 1992;297:24-28.
37. + channel activity in smooth muscle cells. J Gen Physiol. 1994;103:471-486.
38. Shimada T, Somlyo AP. Modulation of voltage-dependent Ca channel current by arachidonic acid and other long-chain fatty acids in rabbit intestinal smooth muscle. J Gen Physiol. 1992;100:27-44.
39. Schmitt H, Meves H. Modulation of neuronal calcium channels by arachidonic acid and related substances. J Membr Biol. 1995;145:233-244.
40. Takenaka T, Horie H, Hori H, Kawakami T. Effects of arachidonic acid and the other long-chain fatty acids on the membrane currents in the squid giant axon. J Membr Biol. 1988;106:141-147.
41. 2+ currents in mouse neuroblastoma cells. J Gen Physiol. 1989;419:95-119.
42. Weylandt K, Kang J, Leaf A. Do polyunsaturated fatty acids in membrane phospholipids prevent ventricular arrhythmias? Lipids. In press.
43. Hock CE, Beck LD, Bodine LC, Reibel DK. Influence of dietary n-3 fatty acids on myocardial ischemia and reperfusion. Am J Physiol. 1990;259(Heart Circ Pysiol):H1518-H1526.
44. Robinson PJ, Noronha JJ, DeGeorge LM, Freed T, Nariai T, Rapaport SI. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids. Brain Res Brain Res Rev. 1992;17:187-214.
45. Richieri GV, Kleinfeld AM. Unbound (free) fatty acids in human serum. J Lipid Res. 1995;36:229-240.
46. Rose H, Convetz M, Fischer Y, Jüngling E, Hennecke T, Kammermeir H. Long chain fatty acid-binding to albumin: reevaluation with directly measured concentrations. Biochim Biophys Acta. 1994;1215:321-326.
47. de Logeril M, Renaud S, Mamelle N, Salen P, Martin J-L, Monjaud I, Guidollet J, Touboul P, Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;143:1454-1459.
48. Burr M, Gilbert JF, Holliday RM, Elwood PC, Fehily AM, Rogers S, Sweetnam PM, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;334:757-761.
49. American Heart Association. Heart and Stroke Facts: 1995 Statistical Supplement. Dallas, Tx: American Heart Assn; 1995.
50. Lipids Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I: reduction in incidence of coronary heart disease. JAMA. 1984;251:351-364.
51. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg, Arbogast P, Smith H, Kushi LH. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995;274:1363-1367.
52. Leaf A, Weber PC. A new era for science in nutrition. Am J Clin Nutr. 1987;45:1048-1053.